• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪素与血流介导的血管舒张作为小儿肾移植受者内皮功能障碍标志物的比较

Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients.

作者信息

Fadel Fatina, Bazraa Hafez M, Abdelrahman Safaa M, Shouman Mohamed Gamal, Sayed Marwa Khaled, Salah Doaa Mohamed, Wahby Aliaa Ahmed, Elgebaly Heba F

机构信息

Department of Pediatrics, Center of Pediatric Nephrology and Transplantation (CPNT), Cairo University, Cairo, Egypt.

EGORD, Egyptian Group of Orphan Renal Diseases, Cairo, Egypt.

出版信息

Open Access Maced J Med Sci. 2017 Apr 13;5(2):222-227. doi: 10.3889/oamjms.2017.032. eCollection 2017 Apr 15.

DOI:10.3889/oamjms.2017.032
PMID:28507632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5420778/
Abstract

BACKGROUND

Renal transplantation (RTx) is the treatment of choice for paediatric end-stage renal disease (ESRD). A major cause of morbidity and mortality after RTx is cardiovascular disease. Independent predictors of cardiovascular events were shown to constitute an endothelial dysfunction (ED). This study aims to evaluate Visfatin serum level in comparison to brachial artery flow-mediated dilatation (FMD) as a marker of endothelial dysfunction in paediatric RTx recipients.

METHODS

Visfatin serum level has been evaluated in 30 patients on regular hemodialysis (HD), 36 patients post-RTx and 30 controls as a measure for ED, and has been compared to brachial artery FMD.

RESULTS

Visfatin level in transplant recipients was significantly lower than the hemodialysis group as well as FMD was better in transplant recipients. In spite of marked improvement of FMD and marked reduction of visfatin in post-RTx no direct statistical correlation was found between serum Visfatin level and flow-mediated dilatation.

CONCLUSION

Pediatric RTx recipients show lower serum Visfatin level and better FMD than those on regular hemodialysis, reflecting less endothelial dysfunction (ED) and less cardiovascular risk. FMD in kidney transplant recipients tends to be less than normal subjects while visfatin level of the same group is similar to controls. Pediatric RTx appears to have a positive impact on the growth development of children with ESRD.

摘要

背景

肾移植(RTx)是小儿终末期肾病(ESRD)的首选治疗方法。RTx后发病和死亡的主要原因是心血管疾病。心血管事件的独立预测因素显示为内皮功能障碍(ED)。本研究旨在评估小儿RTx受者的内脂素血清水平,并与肱动脉血流介导的舒张功能(FMD)进行比较,以作为内皮功能障碍的标志物。

方法

评估了30例接受定期血液透析(HD)的患者、36例RTx后的患者和30例对照者的内脂素血清水平,作为ED的一项指标,并与肱动脉FMD进行比较。

结果

移植受者的内脂素水平显著低于血液透析组,且移植受者的FMD更好。尽管RTx后FMD有显著改善,内脂素显著降低,但血清内脂素水平与血流介导的舒张功能之间未发现直接的统计学相关性。

结论

小儿RTx受者的血清内脂素水平低于接受定期血液透析的患者,FMD更好,这反映出其内皮功能障碍(ED)较少,心血管风险较低。肾移植受者中的FMD往往低于正常受试者,而同一组的内脂素水平与对照组相似。小儿RTx似乎对ESRD患儿的生长发育有积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d64/5420778/9caa9048bba6/OAMJMS-5-222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d64/5420778/141f2b2e730b/OAMJMS-5-222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d64/5420778/9caa9048bba6/OAMJMS-5-222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d64/5420778/141f2b2e730b/OAMJMS-5-222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d64/5420778/9caa9048bba6/OAMJMS-5-222-g002.jpg

相似文献

1
Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients.内脏脂肪素与血流介导的血管舒张作为小儿肾移植受者内皮功能障碍标志物的比较
Open Access Maced J Med Sci. 2017 Apr 13;5(2):222-227. doi: 10.3889/oamjms.2017.032. eCollection 2017 Apr 15.
2
Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?肾移植后内皮功能障碍的正常化伴随着循环内脂素/烟酰胺磷酸核糖转移酶水平的降低。一种内皮损伤的新标志物?
Clin Transplant. 2009 Mar-Apr;23(2):241-8. doi: 10.1111/j.1399-0012.2008.00921.x.
3
Effect of renal transplantation on endothelial function in haemodialysis patients.肾移植对血液透析患者内皮功能的影响。
Nephrol Dial Transplant. 2006 Jan;21(1):203-7. doi: 10.1093/ndt/gfi119. Epub 2005 Sep 6.
4
Endothelial function is more impaired in hemodialysis patients than renal transplant recipients.血液透析患者的内皮功能比肾移植受者受损更严重。
Clin Transplant. 2003 Dec;17(6):528-33. doi: 10.1046/j.1399-0012.2003.00100.x.
5
Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.循环中内脂素水平升高与非糖尿病高血压患者肾脏疾病进展相关。
Am J Hypertens. 2016 Apr;29(4):528-36. doi: 10.1093/ajh/hpv132. Epub 2015 Aug 22.
6
Endothelial dysfunction in renal transplant recipients: role of vitamin D and fibroblast growth factor-23.肾移植受者的内皮功能障碍:维生素D和成纤维细胞生长因子-23的作用。
Transplant Proc. 2015 Mar;47(2):343-7. doi: 10.1016/j.transproceed.2014.12.023.
7
Impact of Adipokines in Brachial Artery Flow-mediated Dilatation in Lupus Nephritis.脂肪因子对狼疮性肾炎肱动脉血流介导的血管舒张功能的影响
Saudi J Kidney Dis Transpl. 2022 Mar-Apr;33(2):272-279. doi: 10.4103/1319-2442.379025.
8
Vascular function in children after renal transplantation.肾移植术后儿童的血管功能
Am J Kidney Dis. 2003 Mar;41(3):684-91. doi: 10.1053/ajkd.2003.50131.
9
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.慢性肾脏病患者血清内脂素浓度与内皮功能障碍
Nephrol Dial Transplant. 2008 Mar;23(3):959-65. doi: 10.1093/ndt/gfm727. Epub 2007 Nov 4.
10
Serum adipokine levels in renal transplant recipients.肾移植受者的血清脂肪因子水平。
Transplant Proc. 2014;46(2):381-4. doi: 10.1016/j.transproceed.2013.11.033.

引用本文的文献

1
The Effect of Kidney Transplantation and Immunosuppressive Therapy on Adipose Tissue Content and Adipocytokine Plasma Concentration-Preliminary Study.肾移植及免疫抑制治疗对脂肪组织含量和血浆脂肪细胞因子浓度的影响——初步研究
Curr Issues Mol Biol. 2025 Apr 7;47(4):255. doi: 10.3390/cimb47040255.

本文引用的文献

1
Systemic arterial hypertension in children following renal transplantation: prevalence and risk factors.儿童肾移植后全身动脉高血压:患病率及危险因素。
Nephrol Dial Transplant. 2012 Aug;27(8):3359-68. doi: 10.1093/ndt/gfr804. Epub 2012 Feb 10.
2
Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.内脂素与慢性肾脏病患者的脂质失调、内皮功能障碍和动脉粥样硬化有关。
J Nephrol. 2011 Mar-Apr;24(2):177-84. doi: 10.5301/jn.2010.3488.
3
Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
肾移植后内皮功能障碍的正常化伴随着循环内脂素/烟酰胺磷酸核糖转移酶水平的降低。一种内皮损伤的新标志物?
Clin Transplant. 2009 Mar-Apr;23(2):241-8. doi: 10.1111/j.1399-0012.2008.00921.x.
4
Relationship between serum pre-B cell colony-enhancing factor/visfatin and atherosclerotic parameters in chronic hemodialysis patients.
Am J Nephrol. 2009;29(1):31-5. doi: 10.1159/000148648. Epub 2008 Jul 26.
5
Effect of renal transplantation on endothelial function in haemodialysis patients.肾移植对血液透析患者内皮功能的影响。
Nephrol Dial Transplant. 2006 Jan;21(1):203-7. doi: 10.1093/ndt/gfi119. Epub 2005 Sep 6.
6
[Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].[慢性肾衰竭患者的透析治疗方法及氧化应激和内皮损伤的选定标志物]
Pol Arch Med Wewn. 2005 Jan;113(1):21-6.
7
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.内脂素:一种由内脏脂肪分泌的蛋白质,可模拟胰岛素的作用。
Science. 2005 Jan 21;307(5708):426-30. doi: 10.1126/science.1097243. Epub 2004 Dec 16.
8
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.1998年至1999年美国医疗保险人群中的慢性肾病与心血管疾病、肾脏替代治疗及死亡风险
J Am Soc Nephrol. 2005 Feb;16(2):489-95. doi: 10.1681/ASN.2004030203. Epub 2004 Dec 8.
9
Effect of dialysis dose and membrane flux in maintenance hemodialysis.透析剂量和膜通量在维持性血液透析中的作用
N Engl J Med. 2002 Dec 19;347(25):2010-9. doi: 10.1056/NEJMoa021583.
10
Endothelial dysfunction in uraemia.
Blood Purif. 2002;20(5):459-61. doi: 10.1159/000063552.